Amlexanox inhibition of TBK1/IKK epsilon Signaling Is a Novel Therapeutic Approach for Multiple Myeloma-Induced Bone Disease / Sun, Qh; Zhang, P; Adamik, J; Marchica, V; Giuliani, N; Silbermann, R; Roodman, Gd; Galson, Dl. - In: JOURNAL OF BONE AND MINERAL RESEARCH. - ISSN 0884-0431. - 32:(2017), pp. S313-S313.
Amlexanox inhibition of TBK1/IKK epsilon Signaling Is a Novel Therapeutic Approach for Multiple Myeloma-Induced Bone Disease.
Marchica, V;Giuliani, N;
2017-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
